ALDH2 Enzyme Identified as Metabolic Achilles’ Heel for APC-Deficient Colorectal Cancer Cells

Researchers find that APC-deficient colorectal cancer cells rely on the ALDH2 enzyme to survive. Discover how this metabolic weakness triggers cancer cell death.

By: AXL Media

Published: Apr 21, 2026, 4:38 AM EDT

Source: Information for this report was sourced from Compuscript Ltd

Targeting the Core Mutation of Colorectal Cancer

Mutations in the Adenomatous Polyposis Coli (APC) gene are considered the "gatekeeper" events in the development of colorectal cancer, present in the vast majority of cases. Despite their prevalence, directly targeting APC mutations with drugs has proven exceptionally difficult for oncologists. A team of researchers has now bypassed this genetic hurdle by identifying a metabolic dependency created by the loss of APC. Their study, published on April 20, 2026, demonstrates that these cancer cells become "addicted" to a specific detoxifying enzyme, ALDH2, to manage the metabolic stress inherent in their rapid growth.

The ALDH2 Detoxification Mechanism

ALDH2 (Aldehyde Dehydrogenase 2) is a critical enzyme primarily known for its role in cellular detoxification and alcohol metabolism. In the context of APC-deficient tumors, the enzyme serves as a vital shield against the accumulation of reactive oxygen species (ROS). When researchers inhibited ALDH2 through computational and experimental models, they found that APC-deficient cells could no longer maintain metabolic homeostasis. The resulting buildup of oxidative stress acts as a catalyst for cellular collapse, a vulnerability not shared by healthy cells with intact APC function.

Activating the Programmed Cell Death Pathway

The study provides a detailed molecular map of how ALDH2 inhibition leads to cancer cell death. The increase in ROS following the enzyme’s removal activates the ASK1/JNK signaling pathway, a known stress-response system that regulates apoptosis. This shift disrupts the balance of apoptotic regulators, specifically increasing the "pro-death" protein BAX and decreasing the "pro-survival" protein Bcl2. The result is a highly selective form of programmed cell death that effectively "tricks" the cancer cells into self-destructing while leaving non-mutated cells relatively unharmed.